Selexis SA and Fusion Antibodies Services Form Partnership to Speed…

Customers will be able to seamlessly go from non-human MAbs to clinical candidate generated in a cGMP ready CHO cell line in 8 months. Clinical candidates are selected based on both expression and…

(PRWeb May 23, 2012)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.